Elanco Animal Health Incorporated Basic Shares Outstanding (Weighted Average)
Elanco Animal Health Incorporated (ELAN) reported Basic Shares Outstanding (Weighted Average) of 499.50 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-05
- Elanco Animal Health Incorporated weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 499.50M shares, a 0.58% increase year-over-year.
- Elanco Animal Health Incorporated weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 497.70M shares, a 0.53% increase year-over-year.
- Elanco Animal Health Incorporated weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 497.00M shares, a 0.55% increase year-over-year.
- Elanco Animal Health Incorporated weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 496.80M shares, a 0.51% increase year-over-year.
- Elanco Animal Health Incorporated weighted average number of shares outstanding, basic for fiscal 2025 was 496.40M shares, a 0.49% increase from fiscal 2024.
- Elanco Animal Health Incorporated weighted average number of shares outstanding, basic for fiscal 2024 was 494.00M shares, a 0.35% increase from fiscal 2023.
- Elanco Animal Health Incorporated weighted average number of shares outstanding, basic for fiscal 2023 was 492.30M shares, a 0.82% increase from fiscal 2022.
- Elanco Animal Health Incorporated weighted average number of shares outstanding, basic for fiscal 2022 was 488.30M shares, a 0.23% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | 499.50M shares 10-Q · filed 2026-08-05 | 498.60M shares 10-Q · filed 2026-08-05 | 498.07M shares derived: average of 3 quarters · filed 2026-08-05 | 497.75M shares derived: average of 4 quarters · filed 2026-08-05 | ||
| 2026-03-31 | 497.70M shares 10-Q · filed 2026-05-06 | 497.35M shares derived: average of 2 quarters · filed 2026-05-06 | 497.17M shares derived: average of 3 quarters · filed 2026-05-06 | 497.02M shares derived: average of 4 quarters · filed 2026-08-05 | ||
| 2025-12-31 | 497.00M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | 496.90M shares derived: average of 2 quarters · filed 2026-02-24 | 496.80M shares derived: average of 3 quarters · filed 2026-08-05 | 496.40M shares 10-K · filed 2026-02-24 | ||
| 2025-09-30 | 496.80M shares 10-Q · filed 2025-11-05 | 496.70M shares derived: average of 2 quarters · filed 2026-08-05 | 496.20M shares 10-Q · filed 2025-11-05 | 495.70M shares derived: average of 4 quarters · filed 2026-08-05 | ||
| 2025-06-30 | 496.60M shares 10-Q · filed 2026-08-05 | 495.90M shares 10-Q · filed 2026-08-05 | 495.33M shares derived: average of 3 quarters · filed 2026-08-05 | 495.07M shares derived: average of 4 quarters · filed 2026-08-05 | ||
| 2025-03-31 | 495.10M shares 10-Q · filed 2026-05-06 | 494.70M shares derived: average of 2 quarters · filed 2026-05-06 | 494.57M shares derived: average of 3 quarters · filed 2026-05-06 | 494.48M shares derived: average of 4 quarters · filed 2026-05-06 | ||
| 2024-12-31 | 494.30M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | 494.30M shares derived: average of 2 quarters · filed 2026-02-24 | 494.27M shares derived: average of 3 quarters · filed 2026-02-24 | 494.00M shares 10-K · filed 2026-02-24 | ||
| 2024-09-30 | 494.30M shares 10-Q · filed 2025-11-05 | 494.25M shares derived: average of 2 quarters · filed 2025-11-05 | 493.90M shares 10-Q · filed 2025-11-05 | 493.65M shares derived: average of 4 quarters · filed 2026-02-24 | ||
| 2024-06-30 | 494.20M shares 10-Q · filed 2025-08-07 | 493.70M shares 10-Q · filed 2025-08-07 | 493.43M shares derived: average of 3 quarters · filed 2026-02-24 | 493.25M shares derived: average of 4 quarters · filed 2026-02-24 | ||
| 2024-03-31 | 493.20M shares 10-Q · filed 2025-05-07 | 493.05M shares derived: average of 2 quarters · filed 2026-02-24 | 492.93M shares derived: average of 3 quarters · filed 2026-02-24 | 492.85M shares derived: average of 4 quarters · filed 2026-02-24 | ||
| 2023-12-31 | 492.90M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | 492.80M shares derived: average of 2 quarters · filed 2026-02-24 | 492.73M shares derived: average of 3 quarters · filed 2026-02-24 | 492.30M shares 10-K · filed 2026-02-24 | ||
| 2023-09-30 | 492.70M shares 10-Q · filed 2024-11-07 | 492.65M shares derived: average of 2 quarters · filed 2024-11-07 | 492.10M shares 10-Q · filed 2024-11-07 | 491.18M shares derived: average of 4 quarters · filed 2025-02-25 | ||
| 2023-06-30 | 492.60M shares 10-Q · filed 2024-08-08 | 491.80M shares 10-Q · filed 2024-08-08 | 490.67M shares derived: average of 3 quarters · filed 2025-02-25 | 490.10M shares derived: average of 4 quarters · filed 2025-02-25 | ||
| 2023-03-31 | 491.10M shares 10-Q · filed 2024-05-08 | 489.70M shares derived: average of 2 quarters · filed 2025-02-25 | 489.27M shares derived: average of 3 quarters · filed 2025-02-25 | 489.05M shares derived: average of 4 quarters · filed 2025-02-25 | ||
| 2022-12-31 | 488.30M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | 488.35M shares derived: average of 2 quarters · filed 2025-02-25 | 488.37M shares derived: average of 3 quarters · filed 2025-02-25 | 488.30M shares 10-K · filed 2025-02-25 | ||
| 2022-09-30 | 488.40M shares 10-Q · filed 2023-11-07 | 488.40M shares derived: average of 2 quarters · filed 2023-11-07 | 488.30M shares 10-Q · filed 2023-11-07 | 488.05M shares derived: average of 4 quarters · filed 2023-11-07 | ||
| 2022-06-30 | 488.40M shares 10-Q · filed 2023-08-07 | 488.20M shares 10-Q · filed 2023-08-07 | 487.93M shares derived: average of 3 quarters · filed 2023-08-07 | 487.77M shares derived: average of 4 quarters · filed 2023-08-07 | ||
| 2022-03-31 | 488.00M shares 10-Q · filed 2023-05-09 | 487.70M shares derived: average of 2 quarters · filed 2023-05-09 | 487.57M shares derived: average of 3 quarters · filed 2023-05-09 | 487.50M shares derived: average of 4 quarters · filed 2023-05-09 | ||
| 2021-12-31 | 487.40M shares 10-K · filed 2023-03-01 | 487.35M shares derived: average of 2 quarters · filed 2023-03-01 | 487.33M shares derived: average of 3 quarters · filed 2023-03-01 | 487.20M shares 10-K · filed 2024-02-26 | ||
| 2021-09-30 | 487.30M shares 10-K · filed 2023-03-01 | 487.30M shares derived: average of 2 quarters · filed 2023-03-01 | 487.10M shares 10-Q · filed 2022-11-08 | 486.85M shares derived: average of 4 quarters · filed 2023-03-01 | ||
| 2021-06-30 | 487.30M shares 10-K · filed 2023-03-01 | 487.00M shares 10-Q · filed 2022-08-08 | 486.70M shares derived: average of 3 quarters · filed 2023-03-01 | 480.63M shares derived: average of 4 quarters · filed 2023-03-01 | ||
| 2021-03-31 | 486.70M shares 10-K · filed 2023-03-01 | 486.40M shares derived: average of 2 quarters · filed 2023-03-01 | 478.40M shares derived: average of 3 quarters · filed 2023-03-01 | 462.10M shares derived: average of 4 quarters · filed 2023-03-01 | ||
| 2020-12-31 | 486.10M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | 474.25M shares derived: average of 2 quarters · filed 2023-03-01 | 453.90M shares derived: average of 3 quarters · filed 2023-03-01 | 441.40M shares 10-K · filed 2023-03-01 | ||
| 2020-09-30 | 462.40M shares 10-Q · filed 2021-11-05 | 437.80M shares derived: average of 2 quarters · filed 2021-11-05 | 426.50M shares 10-Q · filed 2021-11-05 | 413.10M shares derived: average of 4 quarters · filed 2022-02-28 | ||
| 2020-06-30 | 413.20M shares 10-Q · filed 2021-08-09 | 408.50M shares 10-Q · filed 2021-08-09 | 396.67M shares derived: average of 3 quarters · filed 2022-02-28 | 390.40M shares derived: average of 4 quarters · filed 2022-02-28 | ||
| 2020-03-31 | 403.90M shares 10-Q · filed 2021-05-07 | 388.40M shares derived: average of 2 quarters · filed 2022-02-28 | 382.80M shares derived: average of 3 quarters · filed 2022-02-28 | 378.52M shares derived: average of 4 quarters · filed 2022-02-28 | ||
| 2019-12-31 | 372.90M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | 372.25M shares derived: average of 2 quarters · filed 2022-02-28 | 370.07M shares derived: average of 3 quarters · filed 2022-02-28 | 369.00M shares 10-K · filed 2022-02-28 | ||
| 2019-09-30 | 371.60M shares 10-Q · filed 2020-11-06 | 368.65M shares derived: average of 2 quarters · filed 2020-11-06 | 367.70M shares 10-Q · filed 2020-11-06 | 367.45M shares derived: average of 4 quarters · filed 2021-03-01 | ||
| 2019-06-30 | 365.70M shares 10-Q · filed 2020-07-30 | 365.70M shares 10-Q · filed 2020-07-30 | 366.07M shares derived: average of 3 quarters · filed 2021-03-01 | 349.85M shares derived: average of 4 quarters · filed 2021-03-01 | ||
| 2019-03-31 | 365.70M shares 10-Q · filed 2020-05-07 | 366.25M shares derived: average of 2 quarters · filed 2021-03-01 | 344.57M shares derived: average of 3 quarters · filed 2021-03-01 | 331.75M shares derived: average of 4 quarters · filed 2021-03-01 | ||
| 2018-12-31 | 366.80M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | 334.00M shares derived: average of 2 quarters · filed 2021-03-01 | 320.43M shares derived: average of 3 quarters · filed 2021-03-01 | 313.70M shares 10-K · filed 2021-03-01 | ||
| 2018-09-30 | 301.20M shares 10-Q · filed 2019-11-08 | 365.63M shares 10-Q · filed 2018-11-08 | 297.25M shares derived: average of 2 quarters · filed 2019-11-08 | 296.00M shares 10-Q · filed 2019-11-08 | 365.26M shares 10-Q · filed 2018-11-08 | 241.30M shares derived: average of 4 quarters · filed 2020-02-28 |
| 2018-06-30 | 293.30M shares 10-Q · filed 2019-08-13 | 293.30M shares 10-Q · filed 2019-08-13 | 221.34M shares derived: average of 3 quarters · filed 2020-02-28 | 257.32M shares derived: average of 4 quarters · filed 2020-02-28 | ||
| 2018-03-31 | 293.30M shares 10-Q · filed 2019-05-14 | 185.35M shares derived: average of 2 quarters · filed 2020-02-28 | 245.32M shares derived: average of 3 quarters · filed 2020-02-28 | |||
| 2017-12-31 | 77.41M shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | 221.34M shares derived: average of 2 quarters · filed 2020-02-28 | 293.30M shares 10-K · filed 2020-02-28 | |||
| 2017-09-30 | 365.26M shares 10-Q · filed 2018-11-08 | 365.26M shares 10-Q · filed 2018-11-08 | ||||
| 2016-12-31 | 293.29M shares 10-K · filed 2019-02-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |